Mortality Reduction After Oral Azithromycin Contingency: Mortality Study
Status:
Completed
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
MORDOR was a cluster-randomized placebo controlled trial that assessed the efficacy of mass
azithromycin distributions for the prevention of childhood mortality. All communities were
subsequently treated with mass azithromycin for one year. The present trial re-randomized
communities to azithromycin or placebo for the fourth and fifth year of the study.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Bill and Melinda Gates Foundation The Carter Center